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Synthesis and rhodium complexes of macrocyclic
PNP and PONOP pincer ligands†
Thomas M. Hood, Matthew R. Gyton and Adrian B. Chaplin *
The synthesis of macrocyclic variants of commonly employed phosphine-based pincer ligands derived
from lutidine (PNP-14) and 2,6-dihydroxypyridine (PONOP-14) is described, where the P-donors are
trans-substituted with a tetradecamethylene linker. This was accomplished using an eight-step procedure
involving borane protection, ring-closing olefin metathesis, chromatographic separation from the cis-
substituted diastereomers, and borane deprotection. The rhodium coordination chemistry of these ligands
has been explored, aided by the facile synthesis of 2,2’-biphenyl (biph) adducts [Rh(PNP-14)(biph)][BArF4]
and [Rh(PONOP-14)(biph)][BArF4] (Ar
F = 3,5-(CF3)2C6H3). Subsequent hydrogenolysis enabled generation
of dihydrogen, ethylene and carbonyl derivatives; notably the ν(CO) bands of the carbonyl complexes
provide a means to compare the donor properties of the new pincer ligands with established
acyclic congeners.
Introduction
Phosphine-based pincers are an important ligand class in
organometallic chemistry and catalysis, enabling a diverse
variety of metal-based reactivity.1 Their ability to support reac-
tive metal fragments is often exploited in the literature, with
notable examples including a σ-methane complex,2 alkane
dehydrogenation catalysts,3 and complexes capable of enacting
the activation of C(sp3)–F bonds.4 Although mer-tridentate
donor geometries are in principle highly tuneable and adapt-
able ligand scaffolds, the majority of phosphine-based pincers
employed in the literature feature homoleptic aryl and alkyl
phosphine donors, exemplified in the case of lutidine- and
2,6-dihydroxypyridine-derived variants by PNP-tBu and
PONOP-tBu (Chart 1).5,6 Motivated by the potential to exploit
additional reaction control though their unique steric profile,
use in the construction of interlocked assemblies, and as an
extension of our related work with NHC-based pincer
ligands,7,8 we became interested in developing the chemistry
of macrocyclic phosphine-based pincers. We herein describe
the racemic synthesis of the first macrocyclic pincers PNP-14
and PONOP-14, where the chiral P-donors are trans-substituted
with a tetradecamethylene linker, and some representative
complexes with rhodium.9
Results and discussion
Preparation of borane protected ligands
PNP-14·2BH3 (trans-1a) and PONOP-14·2BH3 (trans-1b) were
prepared from commercially available tert-butyldichloro-
phosphine using the seven-step synthesis outlined in
Scheme 1. Amination of the starting material,10 enabled selec-
tive mono-alkylation (2, δ31P 73.3) and following treatment with
HCl chloro-tert-butyl-octen-7-yl-phosphine 3 (δ31P 128.7) was
obtained in 92% yield over three steps. Substitution of 3 by
nucleophiles derived from the deprotonation of 2,6-dihydroxy-
pyridine hydrochloride or 2,6-lutidine affords acyclic 4a (δ31P
33.7) and 4b (δ31P 144.7) as inseparable mixtures of diastereo-
mers in 55% and 72% yield, respectively, after borane protec-
Chart 1
†Electronic supplementary information (ESI) available: NMR, IR and ESI-MS
spectra of new compounds, and selected reactions (PDF). Primary NMR data
(MNOVA). CCDC 1966918–1966922. For ESI and crystallographic data in CIF or
other electronic format see DOI: 10.1039/c9dt04474d
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tion at −78 °C and purification by chromatography. Thereafter,
olefin metathesis of 4a/b under dilute conditions (<4 mmol
L−1) using Grubbs’ 1st generation catalyst generated the corres-
ponding macrocycles (cis-5a/b, δ31P 33.8/144.8; trans-5a/b, δ31P
34.0/143.4). The component diastereomers of 5a/b were separated
using column chromatography and subsequently hydrogenated
using Wilkinson’s catalyst to produce the saturated derivatives
(cis-1a/b, δ31P 33.3/145.1; trans-1a/b, δ31P 33.9/144.1). In this way
trans-1a/b were obtained as analytically pure racemates, in practi-
cally useful overall yields of 14/22%, with their configurations
confirmed by single crystal X-ray diffraction (Fig. 1).
Deprotection
Deprotection of phosphine–boranes is commonly achieved by
reactions with excess amine.11 Gratifyingly, treatment of trans-1a
with neat Et2NH at 85 °C resulted in complete conversion to the
free-base PNP-14 (δ31P 4.5) within 36 h, which was subsequently
isolated in quantitative yield on removal of volatiles. Reactions
between trans-1b and Et2NH under a range of conditions were,
however, characterised by a significant degree of ligand
decomposition that we ascribe to rupture of at least one of the
P–O bonds.12 Evaluation of a range of other deprotection
methods13 gave similar outcomes (see ESI†) and consequently we
have so far been unable to obtain pure samples of the free-base.
Nevertheless, conditions under which PONOP-14 (δ31P 146.5) can
be generated in situ in 69–83% purity were identified: prolonged
stirring of trans-1b (3.8 mmol L−1) in 1 : 1 THF : Et2NH at 19 °C.
Rhodium complexes
As convenient {Rh(pincer)}+ synthons, the synthesis of five
coordinate derivatives [Rh(pincer)(biph)][BArF4] (pincer =
PNP-14, 6a; PONOP-14, 6b; biph = 2,2′-biphenyl; ArF = 3,5-
(CF3)2C6H3) were targeted (Scheme 2). Exploiting a rhodium(III)
precursor first described by Jones,14 and informed by previous
work in our laboratories,7,15,16 6a/b were obtained as analytically
pure materials in good isolated yield (79/69%) using a one-pot pro-
cedure involving substitution reactions of [Rh(biph)(dtbpm)Cl]
(dtbpm = bis(di-tert-butylphosphino)methane) with isolated
Scheme 1 Preparation of PNP-14·2BH3 (trans-1a) and PONOP-14·2BH3 (trans-1b).
Fig. 1 Solid-state structures of trans-1a (left) and trans-1b (right). Thermal ellipsoids drawn at 50% probability; hexane solvent (trans-1b) omitted for
clarity. Selected bond lengths (Å): trans-1a, P2–B2, 1.918(2), P3–B3, 1.922(2); trans-5b, P2–B2, 1.903(3), P3–B3, 1.898(3).
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PNP-14 or in situ generated samples of PONOP-14 in the weakly
coordinating solvent fluorobenzene17 and subsequent addition of
Na[BArF4] as a halide abstracting agent. Complexes 6a and 6b are
characterised in solution by pairs of 31P resonances centred at
δ 43.1 (1JRhP = 110 Hz)/38.4 (
1JRhP = 113 Hz) and δ 191.1 (
1JRhP =
110 Hz)/182.9 (1JRhP = 121 Hz), which display diagnostic trans-phos-
phine 2JPP coupling of 339 and 372 Hz, respectively, and indicate
adoption of C1 symmetry. Whilst the acyclic congeners [Rh(pincer)
(biph)][BArF4] (pincer = PNP-tBu, 6a′; PONOP-tBu, 6b′) highlight
the propensity for dynamic pseudorotation of the biph ligand on
the NMR timescale,15 the tetradecamethylene linker appears to pre-
clude such fluxionality in 6a/6b.
The solid-state structures of 6a/6b demonstrate the adop-
tion of distorted square pyramidal metal geometries, inferred
from solution (Fig. 2). The methylene chains of the pincer
ligands are skewed to one side of the basal plane, presumably
to minimise steric buttressing with the biph ligand, and con-
torted to enable adoption of a weak γ-agostic interactions
(R ̲h ̲1̲⋯H–C̲1̲2 ̲9 ̲ = 3.184(2) Å 6a; 2.925(5) Å, 6b).18 Agostic inter-
actions of comparable magnitude are observed in 6a′/6b′ and
closely related rhodium 2,2′-biphenyl complexes of a NHC-
based macrocyclic pincer ligand.7,15
Reaction of 6a/b with dihydrogen (1 atm) in 1,2-difluoro-
benzene (DFB)17 resulted in hydrogenolysis of the biph ligand
and formation of 7a/b [δ31P 65.9 (
1JRhP = 120 Hz)/δ31P 211.5
(1JRhP = 127 Hz)], but elevated temperature and prolonged reac-
tions times were required for complete conversion (t = 2 days/5
days at 85 °C, Scheme 2). In both cases, no organometallic
intermediates were observed during this reaction and biphenyl
was the sole by-product. The spectroscopic characteristics are
consistent with formulation of 7a/b as C2 symmetric rhodium(I)
dihydrogen complexes, with broad 2H resonances at δ
−10.76/−8.51 that exhibit short spin–lattice relaxation (T1 = 45
± 11/48 ± 6 ms) at 298 K (600 MHz, Ar) the most diagnostic.19
Subsequent reaction in situ with ethylene (1 atm) confers the
corresponding C2 symmetric π-complexes 8a/8b [δ31P 53.0 (1JRhP
= 125 Hz)/δ31P 199.1 (
1JRhP = 129 Hz)], with concomitant for-
mation of ethane, in quantitative spectroscopic yield within
5 min at RT. Coordination of ethylene is substantiated by
chemically inequivalent 2H signals at δ 3.70/3.52 and 3.95/
3.70, and 13C resonances at δ 55.0 (1JRhC = 12 Hz) and 59.5
(1JRhC = 11 Hz), which display appreciable coupling to
103Rh,
for 8a and 8b respectively. Finally, C2 symmetric carbonyl com-
pounds 9a/b [δ31P 67.5 (
1JRhP = 122 Hz)/δ31P 210.8 (
1JRhP =
128 Hz)] are obtained by substitution of ethylene on reaction
of 8a/b with carbon monoxide (1 atm <5 min at RT), isolated
from solution in 96/72% yield overall from 6a/b and fully
characterised, including in the case of 9b in the solid state by
Scheme 2 Preparation of rhodium complexes of PNP-14 and PONOP-14.
Fig. 2 Solid-state structures of 6a (left), 6b (centre) and 9b (not unique, Z’ = 2; right). Thermal ellipsoids drawn at 50%, 30% and 30% probability,
respectively; minor disordered component (9b, methylene chain) and anions omitted. Selected bond lengths (Å) and bond angles (°): 6a: Rh1–C4,
2.003(2); Rh1–C15, 2.028(2); Rh1–P2, 2.3340(4), Rh1–P3, 2.2801(4); Rh1–N101, 2.142(1); P2–Rh1–P3, 163.85(2); N101–M1–C15, 172.93(6); R ̲h̲1 ̲⋯H–
C ̲1 ̲2̲9 ̲, 3.184(2); Rh1–P3–C130, 103.53(6); 6b: Rh1–C4, 2.065(5); Rh1–C15, 2.034(5); Rh1–P2, 2.330(1), Rh1–P3, 2.243(1); Rh1–N101, 2.091(4); P2–
Rh1–P3, 159.89(5); N101–M1–C15, 171.2(2); R ̲h̲1 ̲⋯H–C ̲1̲2 ̲9̲, 2.925(5); Rh1–P3–C130, 103.0(2); 9b: Rh1–C4, 1.844(5); C4–O5, 1.141(7); Rh1–P2, 2.291
(1); Rh1–P3, 2.256(1); Rh1–N101, 2.051(3); P2–Rh1–P3, 160.67(4); N101–Rh1–C4, 174.0(2); Rh11–C14, 1.846(6); C14–O15, 1.147(8); Rh11–P12, 2.288
(2); Rh11–P13, 2.250(2); Rh11–N201, 2.034(4); P12–Rh11–P13, 161.16(7); N201–Rh11–C14, 172.0(3).
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X-ray diffraction (Fig. 2). The ν(CO) bands of rhodium(I) carbo-
nyl derivatives are diagnostic reporter groups for the donor
properties of pincer ligands.20,21 Comparison of the carbonyl
bands of 9a/b with those of acyclic congeners 9a/b′,15,22
recorded under the same conditions, suggests PNP-14 and
PONOP-14 are marginally weaker net donors than PNP-tBu
and PONOP-tBu, respectively (Table 1). By reference to IR data
reported for [Rh(PNP-iPr)(CO)][BArF4] (9a″; PNP-iPr = 2,6-
(iPr2PCH2)2C5H3N) and trends established for monodentate
phosphines, these minor differences are in line with changes
in the phosphine/phosphinite substituents alone.20,23
Conclusions
An eight-step procedure for the synthesis of two macrocyclic
phosphine-based pincer ligands, where the P-donors are trans-
substituted with a tetradecamethylene linker, has been devel-
oped. These ligands are derived from lutidine (PNP-14) and
2,6-dihydroxypyridine (PONOP-14), with key steps involving
borane protection, ring-closing olefin metathesis, chromato-
graphic separation from the cis-substituted diastereomers, and
borane deprotection. The final step was accomplished by borane
transfer to diethylamine, but a non-trivial amount of decompo-
sition could not be avoided in the case of the phosphinite pincer.
The rhodium coordination chemistry of these ligands has been
explored, with 2,2′-biphenyl (biph) complexes [Rh(PNP-14)
(biph)][BArF4] and [Rh(PONOP-14)(biph)][BAr
F
4] conveniently
accessed by substitution reactions of [Rh(biph)(dtbpm)Cl]
(dtbpm = bis(di-tert-butylphosphino)methane), followed by
halide abstraction. These five-coordinate rhodium(III) complexes
are well-defined synthons for the generation of rhodium(I) dihy-
drogen, ethylene and carbonyl derivatives, following hydrogenoly-
sis of the biph ligand that serves as an ‘organometallic protecting
group’. By comparison with the ν(CO) bands of rhodium(I) carbo-
nyl adducts, determined by IR spectroscopy in CH2Cl2, PNP-14
and PONOP-14 can be considered to be marginally weaker net
donors than their respective homoleptic tert-butyl substituted
congeners PNP-tBu and PONOP-tBu, respectively.
Experimental
General methods
All manipulations were performed under an atmosphere of
argon using Schlenk and glove box techniques unless other-
wise stated. Glassware was oven dried at 150 °C overnight and
flame-dried under vacuum prior to use. Molecular sieves were
activated by heating at 300 °C in vacuo overnight. Dihydrogen
and ethylene were dried by passage through a stainless-steel
column of activated 3 Å molecular sieves prior to use.
Fluorobenzene and 1,2-difluorobenzene (DFB) were pre-dried
over Al2O3, distilled from calcium hydride and dried twice over
3 Å molecular sieves.17 CD2Cl2 was freeze–pump–thaw
degassed and dried over 3 Å molecular sieves. C6D6 was dis-
tilled from sodium and stored over 3 Å molecular sieves. THF,
dioxane, diethyl ether and benzene were distilled from
sodium/benzophenone and stored over 3 Å molecular sieves.
Et2NH was distilled from CaH2. SiMe4 was distilled from liquid
Na/K alloy and stored over a potassium mirror. Other an-
hydrous solvents were purchased from Acros Organics or
Sigma-Aldrich, freeze–pump–thaw degassed and stored over
3 Å molecular sieves. LiHMDS was resublimed before use.
nBuLi was titrated before use.24 TMEDA was distilled from
sodium/benzophenone and stored over 3 Å molecular sieves.
Diethylamino-tert-butyl-chlorophosphine (yield = 98%),10
BrMgC8H15,
25 Wilkinson’s catalyst,26 Na[BArF4],
27 and
[Rh(biph)(dtbpm)Cl],14 were synthesised according to pub-
lished procedures. All other reagents are commercial products
and were used as received. NMR spectra were recorded on
Bruker spectrometers under argon at 298 K unless otherwise
stated. Chemical shifts are quoted in ppm and coupling con-
stants in Hz. NMR spectra in DFB and THF : Et2NH were
recorded using an internal capillary of C6D6. ESI-MS were
recorded on Bruker Maxis Plus (HR) or Agilent 6130B single
Quad (LR) instruments. Infrared spectra were recorded on a
Jasco FT-IR-4700 using a KBr transmission cell in CH2Cl2.
Microanalyses were performed at the London Metropolitan
University by Stephen Boyer.
Preparation of PNP-14·2BH3 (trans-1a) and PONOP-14·2BH3
(trans-1b)
Preparation of diethylamino-tert-butyl-octen-7-yl-phosphine
2. A solution of diethylamino-tert-butyl-chlorophosphine
(3.19 g, 16.3 mmol) in THF (30 mL) was cooled to −78 °C and
a solution of BrMgC8H15 (43 mL, 0.38 M) in THF added drop-
wise over 30 minutes. The suspension was allowed to warm to
ambient temperature and stirred for 16 h. The solution was
concentrated under vacuum and the product extracted into
hexane. Dioxane (10 mL) was added and the resulting suspen-
sion filtered, to afford the product on removal of the volatiles
in vacuo, which was carried forward without further purifi-
cation. Yield: 4.21 g (95%).
1H NMR (600 MHz, C6D6): δ 5.80 (ddt,
3JHH = 16.9,
3JHH =
10.2, 3JHH = 6.7, 1H, CH̲vCH2), 5.02–5.08 (m, 1H, CHvCH̲2),
4.98–5.01 (m, 1H, CHvCH̲2), 2.90–2.97 (m, 4H, NCH2),
1.98–2.04 (m, 2H, CH̲2CHvCH2), 1.72–1.78 (m, 1H, CH2),
1.13–1.66 (m, 9H, CH2), 1.06 (d, 9H,
3JPH = 11.8, tBu), 1.00
(t, 6H, 3JHH = 7.1, NCH2CH̲3).
13C{1H} NMR (151 MHz, C6D6): δ 139.2 (s, C̲HvCH2), 114.6
(s, CHvC̲H2), 44.5 (br, NCH2), 34.2 (s, C̲H2CHvCH2), 32.5 (d,
1JPC = 20, tBu{C}), 31.7 (d, JPC = 12, CH2), 29.5 (s, CH2), 29.4
Table 1 Carbonyl stretching frequencies (CH2Cl2)
Pincer complex ν(CO)/cm−1
[Rh(PNP-14)(CO)][BArF4] 9a 1997
[Rh(PNP-tBu)(CO)][BArF4] 9a′
15 1990
[Rh(PNP-iPr)(CO)][BArF4] 9a″
20 1998
[Rh(PONOP-14)(CO)][BArF4] 9b 2020
[Rh(PONOP-tBu)(CO)][BArF4] 9b′
15 2016
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(s, CH2), 27.6 (d,
2JPC = 16, tBu{CH3}), 26.6 (d, JPC = 18, CH2),
23.2 (d, 1JPC = 19, CH2), 15.2 (d,
4JPC = 2, NCH2C̲H3).
31P{1H} NMR (243 MHz, C6D6): δ 73.3 (s).
Preparation of chloro-tert-butyl-octen-7-yl-phosphine 3. HCl
in diethyl ether (151 mL, 1 M, 151 mmol) was added to a solu-
tion of 2 (20.5 g, 75.5 mmol) in hexane (400 mL) at 0 °C. The
suspension was allowed to warm to ambient temperature,
stirred for 2 h and then allowed to stand for 16 h before being
filtered. Analysis of the filtrate by 31P NMR spectroscopy indi-
cated the partial formation of 3·HCl (δ31P 46.9), which was sub-
sequently deprotonated by addition a stoichiometric amount
of LiHMDS (0.479 g, 2.86 mmol) suspended in hexane
(10 mL). The resulting suspension was stirred for 1 h before
allowing the precipitate to settle out, filtered and the product
obtained on removal of the volatiles removed in vacuo, which
was carried forward without further purification. Yield: 17.6 g
(99%).
1H NMR (500 MHz, C6D6): δ 5.77 (ddt,
3JHH = 16.8,
3JHH =
10.0, 3JHH = 6.5, 1H, CH̲vCH2), 5.01–5.06 (m, 1H, CHvCH̲2),
4.97–5.01 (m, 1H, CHvCH̲2), 1.92–2.00 (m, 2H,
CH̲2CHvCH2), 1.15–1.83 (m, 10H, CH2), 0.99 (d,
3JPH = 12.8,
9H, tBu).
13C{1H} NMR (126 MHz, C6D6): δ 139.1 (s, C̲HvCH2), 114.6
(s, CHvC ̲H2), 34.1 (s, C̲H2CHvCH2), 32.4 (d, 1JPC = 29, tBu
{C}), 31.1 (d, JPC = 11, CH2), 30.7 (d,
1JPC = 36, CH2), 29.2 (s, 2 ×
CH2), 25.9 (d, JPC = 15, CH2), 25.5 (d,
2JPC = 17, tBu{CH3}).
31P{1H} NMR (162 MHz, C6D6): δ 128.7 (s).
Preparation of 4a. A solution of 2,6-lutidine (1.22 g,
11.4 mmol) and TMEDA (3.40 mL, 22.7 mmol) in diethyl ether
(30 mL) at 0 °C was treated dropwise with nBuLi (13.7 mL, 1.66
M, 22.7 mmol). The reaction was warmed to room temperature
and stirred for 16 h resulting in a deep red solution, which
was cooled to −78 °C and treated with a solution of 3 (5.48 g,
23.3 mmol) in diethyl ether (60 mL), then warmed to room
temperature and stirred for 2 days. The suspension was fil-
tered, the filtrate reduced to dryness and the crude product
extracted into hexane (50 mL). The resulting solution was
washed with degassed water, dried over MgSO4 and the solvent
removed in vacuo to afford a colourless oil, which was redis-
solved in THF (150 mL), cooled to −78 °C, treated with
BH3·SMe2 (1.10 mL, 11.6 mmol) and an aliquot analysed by
31P NMR spectroscopy. Additional BH3·SMe2 was then added
portion-wise (0.40 mL, 4.2 mmol, then 0.60 mL, 6.3 mmol) at
−78 °C until no free phosphine remained by 31P NMR spec-
troscopy. In air, the solution was treated with aqueous
ammonium chloride (150 mL), extracted into ethyl acetate
(150 mL), dried over MgSO4 and the volatiles removed in vacuo.
The product was obtained as a colourless oil after repeated
purification by column chromatography as a mixture of
diastereomers (10% EtOAc in hexane; RF = 0.19). Yield: 3.30 g
(55%).
1H NMR (500 MHz, CDCl3): δ 7.55 (t,
3JHH = 7.7, 1H, py),
7.19–7.24 (m, 2H, py), 5.72–5.85 (m, 2H, CH̲vCH2), 4.95–5.01
(m, 2H, CHvCH̲2), 4.91–4.95 (m, 2H, CHvCH̲2), 3.09–3.20 (m,
4H, pyCH̲2), 1.97–2.06 (m, 4H, CH̲2CHvCH2), 1.67–1.85 (m,
2H, CH2), 1.49–1.62 (m, 4H, CH2), 1.21–1.38 (m, 14H, CH2),
1.16 (d, 3JPH = 13.3, 7.3H, tBu), 1.12 (d,
3JPH = 13.4, 10.7H, tBu),
−0.05–0.77 (m, 6H, BH3). Some peaks duplicated because of
diastereomers.
13C{1H} NMR (126 MHz, CDCl3): δ 154.4 (dd,
2JPC = 6,
4JPC =
1, py), 154.2 (dd, 2JPC = 5,
4JPC = 2, py), 138.97 (s, C ̲HvCH2)
138.96 (s, C̲HvCH2), 136.8 (t,
4JPC = 2, py), 136.7 (t,
4JPC = 2,
py), 123.3 (app t, JPC = 3, py), 123.2 (app t, JPC = 3, py), 114.5 (s,
CHvC̲H2), 33.8 (s, C̲H2CHvCH2), 31.74 (d,
2JPC = 13, CH2),
31.70 (d, 2JPC = 13, CH2), 31.39 (d,
1JPC = 26, pyC̲H2), 31.34 (d,
1JPC = 26, pyC̲H2), 28.91 (d,
1JPC = 38, tBu{C}), 28.90 (d,
1JPC = 31,
tBu{C}), 28.90 (s, CH2), 28.88 (s, CH2), 28.8 (br, CH2), 25.8 (t,
2JPC = 2, tBu{CH3}), 23.70 (s, CH2), 23.67 (s, CH2), 20.0 (d,
1JPC =
30, CH2). Some peaks duplicated because of diastereomers.
31P{1H} NMR (162 MHz, CDCl3): δ 33.7 (vbr, fwhm = 150 Hz).
HR ESI-MS (positive ion 4 kV): 554.4366, [M + Na]+ (calcd
554.4368) m/z.
Preparation of 4b. A suspension of 2,6-dihydroxypyridine
hydrochloride (0.890 g, 6.01 mmol) and LiHMDS (3.03 g,
18.1 mmol) in THF (30 mL) was heated at reflux for 16 h. The
resulting suspension was treated dropwise with a solution of 3
(2.90 g, 12.4 mmol) in THF (20 mL) and then heated at reflux
for 16 h. The solvent was removed in vacuo and the crude
product extracted into hexane, to afford a colourless oil on
removal of the volatiles, which was redissolved in THF
(50 mL), cooled to −78 °C, treated BH3·SMe2 (0.85 mL,
12 mmol) and an aliquot analysed by 31P NMR spectroscopy.
Additional BH3·SMe2 was then added (0.12 mL, 1.27 mmol) at
−78 °C until no free phosphine remained by 31P NMR spec-
troscopy. In air, the solution was treated with aqueous
ammonium chloride (50 mL), extracted into ethyl acetate, dried
over MgSO4, filtered and the volatiles removed in vacuo. The
product was obtained as a colourless oil after repeated purifi-
cation by column chromatography as a mixture of diastereo-
mers (2% EtOAc in hexane; RF = 0.22). Yield: 2.31 g (72%).
1H NMR (500 MHz, CDCl3): δ 7.65 (t,
3JHH = 7.9, 1H, py),
6.81 (d, 3JHH = 7.9, 1.0H, py), 6.80 (d,
3JHH = 7.9, 1.0H, py), 5.80
(ddt, 3JHH = 16.9,
3JHH = 10.3,
3JHH = 6.7, 2H, CH̲vCH2),
4.96–5.02 (m, 2H, CHvCH̲2), 4.93 (d,
3JHH = 10.1, 2H,
CHvCH̲2), 2.08–2.24 (m, 2H, CH2), 2.04 (app q,
3JHH = 7, 4H,
CH̲2CHvCH2), 1.79–1.92 (m, 2H, CH2), 1.67–1.78 (m, 4H,
CH2), 1.33–1.47 (m, 12H, CH2), 1.29 (d,
3JPH = 14.1, 9.0H, tBu),
1.29 (d, 3JHH = 14.2, 9.0H, tBu), 0.08–0.92 (m, 6H, BH3). Some
peaks duplicated because of diastereomers.
13C{1H} NMR (126 MHz, CDCl3): δ 158.1 (app t, JPC = 7, py),
142.09 (s, py), 142.05 (s, py), 139.07 (s, C̲HvCH2), 139.06 (s,
C̲HvCH2), 114.5 (s, CHvC̲H2), 111.0 (d,
3JPC = 3, py), 110.8 (d,
3JPC = 3, py), 33.84 (s, C̲H2CHvCH2), 33.83 (s, C̲H2CHvCH2),
32.84 (d, 1JPC = 36, tBu{C}), 32.78 (d,
1JPC = 36, tBu{C}), 31.4 (s,
CH2), 31.3 (s, CH2), 28.90 (s, CH2), 28.89 (s, CH2), 28.80 (s,
CH2), 28.78 (s, CH2), 25.5 (d,
1JPC = 31, CH2), 25.4 (d,
1JPC = 31,
CH2), 24.94 (d,
2JPC = 3, tBu{CH3}), 24.92 (d,
2JPC = 3, tBu
{CH3}), 23.01, (s, CH2), 23.00 (s, CH2). Some peaks duplicated
because of diastereomers.
31P{1H} NMR (162 MHz, CDCl3): δ 144.7 (vbr, fwhm = 160 Hz).
HR ESI-MS (positive ion 4 kV): 558.3953, [M + Na]+ (calcd
558.3950) m/z.
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Preparation of 5a. A solution of 4a (3.30 g, 6.21 mmol) in
CH2Cl2 (1.2 mmol L
−1, 5 L) was treated with 15 mol% [Ru
(PCy3)2Cl2(CHPh)] (0.77 g, 0.94 mmol) in 5 mol% portions in
CH2Cl2 (5 mL) over 3 days with daily sparging with N2 for
30 minutes. The solvent was removed in vacuo and the cis- and
trans-diastereomers were separated as white solids by repeated
purification by column chromatography in air (10% EtOAc in
hexane).
cis-5a (RF = 0.22). Yield: 553 mg (18%).
1H NMR (500 MHz, CDCl3): δ 7.55 (t,
3JHH = 7.7, 1H, py),
7.23 (d, 3JHH = 7.8, 2H, py), 5.27–5.41 (m, 2H, CHvCH), 3.07–3.21
(m, 4H, pyCH̲2), 1.94–2.09 (m, 4H, CH̲2CHvCH), 1.80–1.92 (m,
2H, CH2), 1.47–1.67 (m, 4H, CH2), 1.23–1.45 (m, 14H, CH2), 1.12
(d, 3JPH = 13.3, 18H, tBu), 0.02–0.82 (m, 6H, BH3).
13C{1H} NMR (126 MHz, CDCl3): δ 154.5 (dd,
2JPC = 6,
4JPC =
2, py), 136.9 (t, 4JPC = 1, py), 131.1 (s, CHvCH), 123.3 (app t, JPC =
3, py), 32.1 (s, C̲H2CHvCH), 31.2 (s, CH2), 31.1 (d,
1JPC = 12,
pyC̲H2), 28.9 (d,
1JPC = 31, tBu{C}), 28.7 (s, CH2), 27.5 (s, CH2),
25.8 (d, 2JPC = 2, tBu{CH3}), 23.5 (s, CH2), 19.3 (d,
1JPC = 30, CH2).
31P{1H} NMR (162 MHz, CDCl3): δ 33.8 (vbr, fwhm = 150 Hz).
HR ESI-MS (positive ion 4 kV): 526.4051, [M + Na]+ (calcd
526.4079) m/z.
trans-5a (RF = 0.22). Yield: 840 mg (27%).
1H NMR (500 MHz, CDCl3): δ 7.54 (t,
3JHH = 7.7, 1H, py),
7.17 (d, 3JHH = 7.8, 2H, py), 5.23–5.41 (m, 2H, CHvCH), 3.07–3.20
(m, 4H, pyCH̲2), 1.99–2.07 (m, 4H, CH̲2CHvCH), 1.78–1.92 (m,
2H, CH2), 1.54–1.71 (m, 4H, CH2), 1.28–1.51 (m, 14H, CH2), 1.16
(d, 3JPH = 13.2, 18H, tBu), −0.15–0.73 (m, 6H, BH3).
13C{1H} NMR (126 MHz, CDCl3): δ 154.5 (dd,
2JPC = 5,
4JPC =
2, py), 136.7 (t, 4JPC = 2, py), 131.1 (s, CHvCH), 123.2 (app t,
JPC = 3, py), 31.9 (s, C̲H2CHvCH), 31.0 (d,
2JPC = 11, CH2), 30.8
(d, 1JPC = 26, pyC̲H2), 29.0 (d,
1JPC = 31, tBu{C}), 28.6 (s, CH2),
27.2 (s, CH2), 25.9 (d,
2JPC = 2, tBu{CH3}), 23.5 (s, CH2), 19.8 (d,
1JPC = 30, CH2).
31P{1H} NMR (162 MHz, CDCl3): δ 34.0 (vbr, fwhm = 150 Hz).
HR ESI-MS (positive ion 4 kV): 526.4054, [M + Na]+ (calcd
526.4079) m/z.
Preparation of 5b. A solution of 4b (1.69 g, 3.16 mmol) in
CH2Cl2 (3.2 mmol L
−1, 1 L) was treated with 20 mol%
[Ru(PCy3)2Cl2(CHPh)] (0.52 g, 0.63 mmol) in 5 mol% portions
in CH2Cl2 (3 mL) over four days with daily sparging with N2 for
30 minutes. The solvent was removed in vacuo and the cis- and
trans-diastereomers were separated as white solids by repeated puri-
fication by column chromatography in air (2% EtOAc in hexane).
cis-5b (RF = 0.21). Yield: 520 mg (33%).
1H NMR (500 MHz, CDCl3): δ 7.67 (t,
3JHH = 7.9, 1H, py),
6.95 (d, 3JHH = 8.0, 2H, py), 5.29–5.32 (m, 2H, CHvCH),
2.12–2.24 (m, 2H, CH2), 1.95–2.08 (m, 4H, CH̲2CHvCH),
1.65–1.85 (m, 6H, CH2), 1.30–1.48 (m, 12H, CH2), 1.28 (d,
3JPH = 14.1, 18H, tBu), 0.15–0.92 (m, 6H, BH3). Data for major
isomer only.
13C{1H} NMR (126 MHz, CDCl3): δ 158.2 (d,
2JPC = 5, py),
142.3 (s, py), 131.0 (s, CHvCH), 110.5 (d, 3JPC = 3, py), 32.8 (d,
1JPC = 37, tBu{C}), 32.1 (s, C̲H2CHvCH), 31.1 (d,
2JPC = 14, CH2),
28.7 (s, CH2), 27.7 (s, CH2), 25.5 (d,
1JPC = 31, CH2), 24.9 (d,
2JCH = 3, tBu{CH3}), 22.8 (s, CH2). Data for major isomer only.
31P{1H} NMR (162 MHz, CDCl3): δ 144.8 (vbr, fwhm = 150 Hz).
HR ESI-MS (positive ion 4 kV): 530.3644, [M + Na]+ (calcd
530.3639) m/z.
trans-5b (RF = 0.22). Yield: 540 mg (34%).
1H NMR (500 MHz, CDCl3): δ 7.63 (t,
3JHH = 7.8, 1H, py),
6.76 (d, 3JHH = 7.9, 2H, py), 5.29–5.33 (m, 2H, CHvCH),
2.16–2.33 (m, 2H, CH2), 1.96–2.09 (m, 4H, CH̲2CHvCH),
1.83–1.92 (m, 2H, CH2), 1.32–1.46 (m, 4H, CH2), 1.32–1.46 (m,
12H, CH2), 1.28 (d,
3JPH = 14.0, 18H, tBu), 0.11–0.85 (m, 6H,
BH3). Data for major isomer only.
13C{1H} NMR (126 MHz, CDCl3): δ 158.2 (d,
2JPC = 6, py),
142.0 (s, py), 131.2 (s, CHvCH), 110.1 (d, 3JPC = 3, py), 32.8 (d,
1JPC = 37, tBu{C}), 31.8 (s, C̲H2CHvCH), 31.2 (d,
2JPC = 14, CH2),
28.6 (s, CH2), 27.5 (s, CH2), 25.5 (d,
1JPC = 30, CH2), 24.9 (d,
2JPC = 3, tBu{CH3}), 23.4 (s, CH2). Data for major isomer only.
31P{1H} NMR (162 MHz, CDCl3): δ 143.4 (vbr, fwhm = 180 Hz).
HR ESI-MS (positive ion 4 kV): 530.3634, [M + Na]+ (calcd
530.3639) m/z.
General procedure for the hydrogenation of 5. A suspension
of 5 and [Rh(PPh3)3Cl] (5 mol%) in benzene was freeze–pump–
thaw degassed and placed under dihydrogen (1 atm). The
resulting solution was heated at reflux for 36 h, reduced to
dryness in vacuo, and the product obtained following purifi-
cation by column chromatography in air.
cis-1a (20% EtOAc in hexane, RF = 0.20).
Following the general procedure using cis-5a (80.0 mg,
0.159 mmol) and [Rh(PPh3)3Cl] (7.4 mg, 8.0 μmol) in benzene
(5 mL), the product was isolated as a white solid. Yield:
73.8 mg (92%).
1H NMR (600 MHz, CDCl3): δ 7.55 (t,
3JHH = 7.7, 1H, py),
7.32 (d, 3JHH = 7.8, 2H, py), 3.16 (app d,
2JPH = 12, 4H, pyCH̲2),
1.71–1.82 (m, 2H, CH2), 1.47–1.60 (m, 4H, CH2), 1.21–1.39 (m,
22H, CH2), 1.12 (d,
3JPH = 13.3, 18H, tBu), 0.11–0.72 (br, 6H, BH3).
13C{1H} NMR (151 MHz, CDCl3): δ 153.8 (dd,
2JPC = 4,
4JPC =
2, py), 136.6 (t, 4JPC = 2, py), 123.5 (app t, JPC = 3, py), 31.5 (d,
1JPC = 26, pyC ̲H2), 30.7 (d, 2JPC = 13, CH2), 28.9 (d, 1JPC = 31,
tBu{C}), 28.0 (s, CH2), 27.87 (s, CH2), 27.85 (s, CH2), 27.8 (s,
CH2), 25.7 (d,
2JPC = 2, tBu{CH3}), 22.7 (d,
3JPC = 2, CH2), 20.4
(d, 1JPC = 31, CH2).
31P{1H} NMR (243 MHz, CDCl3): δ 33.3 (vbr, fwhm = 130 Hz).
HR ESI-MS (positive ion 4 kV): 528.4204, [M + Na]+ (calcd
528.4211) m/z.
trans-1a (20% EtOAc in hexane, RF = 0.19).
Following the general procedure using trans-5a (840 mg,
1.67 mmol) and [Rh(PPh3)3Cl] (77.2 mg, 83.4 μmol) in
benzene (50 mL), the product was isolated as a white solid.
Yield: 818 mg (97%).
1H NMR (500 MHz, CDCl3): δ 7.55 (t,
3JHH = 7.7, 1H, py),
7.21 (d, 3JHH = 7.8, 2H, py), 3.13–3.28 (m, 4H, pyCH̲2),
1.75–1.86 (m, 2H, CH2), 1.52–1.68 (m, 4H, CH2) 1.38–1.50 (m,
4H, CH2), 1.26–1.35 (m, 18H, CH2), 1.10 (d,
3JPH = 13.3, 18H,
tBu), 0.05–0.77 (m, 6H, BH3).
13C{1H} NMR (126 MHz, CDCl3): δ 154.7 (dd,
2JPC = 6,
4JPC =
1, py), 136.8 (t, 4JPC = 2, py), 123.0 (app t, JPC = 3, py), 31.5 (d,
1JPC = 26, pyC ̲H2), 30.8 (d, 2JPC = 13, CH2), 29.1 (d, 1JPC = 31,
tBu{C}), 27.91 (s, CH2), 27.89 (s, CH2), 27.74 (s, CH2), 27.71 (s,
Paper Dalton Transactions
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CH2), 25.9 (d,
2JPC = 2, tBu{CH3}), 22.9 (d,
3JPC = 1, CH2), 20.1
(d, 1JPC = 31, CH2).
31P{1H} NMR (162 MHz, CDCl3): δ 33.9 (vbr, fwhm = 150 Hz).
HR ESI-MS (positive ion 4 kV): 528.4209, [M + Na]+ (calcd
528.4211) m/z.
Anal. Calcd for C29H59B2NP2 (505.37 g mol
−1): C, 68.92; H,
11.77; N, 2.77; Found: C, 68.76; H 11.82; N, 2.69.
cis-1b (30% CH2Cl2 in hexane, RF = 0.19).
Following the general procedure using cis-5b (315 mg,
0.620 mmol) and [Rh(PPh3)3Cl] (27.2 mg, 29.4 μmol) in
benzene (30 mL), the product was isolated as a white solid.
Yield: 287 mg (91%).
1H NMR (500 MHz, CDCl3): δ 7.67 (t,
3JHH = 7.9, 1H, py),
6.98 (d, 3JHH = 7.9, 2H, py), 2.12–2.25 (m, 2H, CH2), 1.63–1.82
(m, 6H, CH2), 1.27 (d,
3JPH = 14, 18H, tBu), 1.25–1.49 (m, 20H,
CH2), 0.14–0.88 (m, 6H, BH3).
13C{1H} NMR (126 MHz, CDCl3): δ 158.2 (d,
2JPC = 5, py),
142.2 (s, py), 110.8 (d, 3JPC = 3, py), 32.9 (d,
1JPC = 36, tBu{C}),
30.6 (d, 2JPC = 13, CH2), 27.8 (s, 2 × CH2), 27.5 (s, CH2), 27.3 (s,
CH2), 25.2 (d,
1JPC = 32, CH2), 24.9 (d,
2JPC = 3, tBu{CH3}), 22.1
(s, CH2).
31P{1H} NMR (162 MHz, CDCl3): δ 145.1 (vbr, fwhm = 142 Hz).
HR ESI-MS (positive ion 4 kV): 532.3791, [M + Na]+ (calcd
532.3796) m/z.
trans-1b (30% CH2Cl2 in hexane, RF = 0.20).
Following the general procedure using trans-5b (620 mg,
1.22 mmol) and [Rh(PPh3)3Cl] (56.5 mg, 61.1 μmol) in
benzene (50 mL), the product was isolated as a white. Yield:
623 mg (95%).
1H NMR (500 MHz, CDCl3): δ 7.64 (t,
3JHH = 7.8, 1H, py),
6.81 (d, 3JHH = 7.9, 2H, py), 2.13–2.29 (m, 2H, CH2), 1.85–1.96
(m, 2H, CH2), 1.69–1.83 (m, 4H, CH2), 1.38–1.47 (m, 4H, CH2),
1.28 (d, 3JPH = 13.9, 18H, tBu), 1.23–1.37 (m, 12H, CH2),
0.11–0.99 (m, 6H, BH3).
13C{1H} NMR (126 MHz, CDCl3): δ 158.2 (d,
2JPC = 6, py),
142.1 (s, py), 110.2 (d, 3JPC = 3, py), 32.9 (d,
1JPC = 36, tBu{C}),
30.8 (d, 2JPC = 13, CH2), 27.7 (s, CH2), 27.52 (s, CH2), 27.47 (s,
CH2), 26.9 (s, CH2), 25.5 (d,
1JPC = 31, CH2), 25.0 (d,
2JPC = 3,
tBu{CH3}), 22.7 (s, CH2).
31P{1H} NMR (162 MHz, CDCl3): δ 144.1 (vbr, fwhm = 155 Hz).
HR ESI-MS (positive ion 4 kV): 532.3804, [M + Na]+ (calcd
532.3795) m/z.
Anal. Calcd for C27H55B2NO2P2 (509.31 g mol
−1): C, 63.67;
H, 10.89; N, 2.75; Found: C, 63.66; H, 11.03; N, 2.74.
Preparation of PNP-14
A solution of trans-1a in Et2NH (0.5 mL) was heated at 85 °C
for 2 days within a J Young’s valve NMR tube. Quantitative con-
version was observed by 1H and 31P NMR spectroscopy. The
volatiles were removed in vacuo to afford the product as a col-
ourless oil, which was carried forward without further
purification.
1H NMR (500 MHz, C6D6): δ 7.08 (t,
3JHH = 7.7, 1H, py), 6.90
(d, 3JHH = 7.7, 2H, py), 3.04 (d,
2JHH = 13.0, 2H, pyCH ̲2), 2.87
(dd, 2JHH = 13.0,
2JPH = 2.9, 2H, pyCH̲2), 1.50–1.57 (m, 2H,
CH2), 1.38–1.49 (m, 8H, CH2), 1.27–1.38 (m, 18H, CH2), 1.03
(d, 3JPH = 11, 18H, tBu).
13C{1H} NMR (126 MHz, C6D6): δ 160.4 (d,
2JPC = 8, py),
136.0 (s, py), 120.5 (dd, 3JPC = 6,
5JPC = 2, py), 35.5 (d,
1JPC = 24,
pyC̲H2), 30.8 (d,
1JPC = 12, tBu{C}), 28.5 (s, CH2), 28.2 (s, CH2),
28.1 (s, CH2), 28.0 (s, CH2), 27.6 (d,
2JPC = 14, tBu{CH3}), 27.3
(s, CH2), 27.1 (s, CH2), 24.4 (d,
1JPC = 20, CH2).
31P{1H} NMR (121 MHz, C6D6): δ 4.5 (s).
LR ESI-MS (positive ion, 4 kV): 532.5, [M]+ (calcd 532.3) m/z.
Preparation of PONOP-14
A solution of trans-1b (11.7 mg, 23.0 µmol) in THF (3 mL) was
treated with an equal volume of Et2NH (3 mL) and the result-
ing solution stirred at 19 °C for 8 days. The volatiles were
removed in vacuo to afford the product as a yellow oil in
65–84% purity, as determined by 31P NMR spectroscopy, which
was carried forward without further purification.
31P{1H} NMR (162 MHz, THF : HNEt2, selected data): δ
146.5 (s).
Preparation of [Rh(PNP-14)(biph)][BArF4] (6a)
A suspension of PNP-14 (16.1 mg, 33.7 µmol) and [Rh(biph)
(dtbpm)Cl] (20.0 mg, 33.6 µmol) in PhF (0.50 mL) was
stirred at ambient temperature for 16 h. Na[BArF4] (29.8 mg,
33.6 µmol) was added and the suspension stirred for a
further 4 h before the volatiles were removed in vacuo. The
resulting orange oil was washed with pentane (2 × 1 mL), dried
in vacuo and extracted into CH2Cl2 (2 mL). The product was
obtained as an orange crystalline solid by slow cooling of
CH2Cl2 : hexane (1 : 20) solution to −30 °C. Yield: 42.6 mg
(79%).
1H NMR (500 MHz, CD2Cl2): δ 7.95 (t,
3JHH = 7.9, 1H, py),
7.70–7.76 (m, 8H, ArF), 7.59–7.68 (m, 4H, 2 × py + 2 × biph),
7.56 (br, 4H, ArF), 7.48 (d, 3JHH = 7.6, 1H, biph), 7.10–7.26 (m,
2H, biph), 6.98 (t, 3JHH = 7.3, 1H, biph), 6.50 (t,
3JHH = 7.6, 1H,
biph), 5.63 (d, 3JHH = 8.2, 1H, biph), 3.85–4.04 (m, 2H, pyCH̲2),
3.51–3.76 (m, 2H, pyCH̲2), 2.66–2.78 (m, 1H, CH2), 2.05–2.24
(m, 1H, CH2), 1.74–1.83 (m, 1H, CH2), 1.40–1.70 (m, 10H,
CH2), 1.18–1.39 (m, 7H, CH2), 1.16 (d,
3JPH = 13.3, 9H, tBu),
0.96–1.09 (m, 4H, CH2), 0.66–0.87 (m, 3H, CH2), 0.51 (d,
3JPH =
15, 9H, tBu), 0.19–0.35 (m, 1H, CH2).
13C{1H} NMR (126 MHz, CD2Cl2): δ 162.5 (app t, JPC = 5, py),
162.3 (q, 1JCB = 50, Ar
F), 162.1 (app t, JPC = 3, py), 161.7
(obscured, biph), 152.3 (d app t, 1JRhC = 44,
2JPC = 7, biph),
151.2 (s, biph), 148.9 (s, biph), 140.5 (s, py), 135.4 (s, ArF),
133.9 (s, biph), 129.6 (s, biph), 129.4 (qq, 2JFC = 32,
3JCB = 3,
ArF), 128.5 (s, biph), 126.7 (s, biph), 125.2 (q, 1JFC = 272, Ar
F),
125.1 (s, biph), 124.1 (s, biph), 123.5 (d, 3JPC = 8, py), 123.4 (d,
3JPC = 10, py), 122.4 (s, biph), 121.9 (s, biph), 118.0 (sept,
3JFC =
4, ArF), 40.1 (d, 1JPC = 23, pyC ̲H2), 38.7 (d, 1JPC = 19, pyC̲H2),
34.4 (dd, 1JPC = 16,
3JPC = 5, tBu{C}), 33.0 (ddd,
1JPC = 20,
3JPC =
5, 2JRhC = 2, tBu{C}), 32.0 (d,
2JPC = 14, CH2), 30.3 (s, CH2), 29.7
(s, CH2), 29.54 (s, CH2), 29.51 (s, CH2), 29.43 (d,
2JPC = 4, tBu
{CH3}), 29.37 (s, CH2), 29.3 (s, CH2), 28.0 (s, CH2), 27.3 (s,
CH2), 26.2 (d,
1JPC = 21, PCH2), 25.7 (s, tBu{CH3}), 25.6
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(obscured, CH2), 24.9 (s, CH2), 24.6 (s, CH2), 21.0 (d app t,
1JPC = 16, J = 2, PCH2).
31P{1H} NMR (162 MHz, CD2Cl2): δ 43.1 (dd,
2JPP = 339,
1JRhP = 110, 1P), 38.4 (dd,
2JPP = 339,
1JRhP = 113, 1P).
HR ESI-MS (positive ion, 4 kV): 732.3329, [M]+ (calcd
732.3329) m/z.
Anal. Calcd for C73H73BF24NP2Rh (1596.02 g mol
−1): C,
54.94; H, 4.61; N, 0.88; Found: C, 54.89; H, 4.80; N, 0.86.
Preparation of [Rh(PONOP-14)(biph)][BArF4] (6b)
A suspension of PONOP-14 (17.8 µmol, generated in situ as
described above) and [Rh(biph)(dtbpm)Cl] (10.6 mg,
17.8 µmol) in PhF (0.5 mL) was stirred at ambient temperature
for 16 h. Na[BArF4] (15.8 mg, 17.8 µmol) was added and the
suspension stirred for a further 4 h before the volatiles were
removed in vacuo. The resulting orange oil was washed with
pentane (2 × 1 mL), dried in vacuo and extracted into CH2Cl2
(2 mL). The product was recrystallised by slow diffusion of
hexane into a CH2Cl2 solution (1 : 20). Yield: 19.6 mg (69%).
1H NMR (500 MHz, CD2Cl2): δ 8.11 (t,
3JHH = 8.2, 1H, py),
7.70–7.76 (m, 8H, ArF), 7.65 (d, 3JHH = 7.3, 1H, biph), 7.56 (br,
4H, ArF), 7.54 (obscured, 1H, biph), 7.47 (d, 3JHH = 7.2, 1H,
biph), 7.16–7.21 (m, 2H, biph), 7.15 (d, 3JHH = 8.2, 1H, py), 7.10
(d, 3JHH = 8.2, 1H, py), 7.06 (t,
3JHH = 7.4, 1H, biph), 6.56 (t,
3JHH = 7.7, 1H, biph), 5.32 (d,
3JHH = 8.8, 1H, biph), 2.64–2.86
(m, 2H, CH2), 1.85–2.08 (m, 3H, CH2), 1.60–1.78 (m, 4H, CH2),
1.29 (d, 3JPH = 14.6, 9H, tBu), 1.00–1.58 (m, 13H, CH2),
0.84–0.96 (m, 1H, CH2), 0.65–0.83 (m, 3H, CH2), 0.62 (d,
3JPH =
17.4, 9H, tBu), 0.37–0.48 (m, 2H, CH2).
13C{1H} NMR (126 MHz, CD2Cl2): δ 162.7 (dd,
2JPC = 6,
4JPC
= 2, py), 162.3 (q, 1JCB = 50, Ar
F), 161.5 (dd, 2JPC = 6,
4JPC = 2,
py), 159.1 (ddd, 1JRhC = 32,
2JPC = 11,
2JPC = 5, biph), 151.9
(ddd, 1JRhC = 43,
2JPC = 9,
2JPC = 7, biph), 151.2 (s, biph), 149.1
(br, biph), 147.2 (s, py), 135.4 (s, ArF), 133.9 (s, biph), 129.4
(qq, 2JFC = 32,
3JCB = 3, Ar
F), 129.35 (s, biph), 128.3 (s, biph), 127.6
(biph), 126.2 (s, biph), 125.2 (q, 1JFC = 272, Ar
F), 125.0 (s, biph),
123.3 (s, biph), 122.5 (s, biph), 118.0 (sept, 3JFC = 4, Ar
F), 106.1 (d,
3JPC = 4, py), 105.7 (d,
3JPC = 5, py), 41.6 (dd,
1JPC = 9,
2JRhC = 7,
tBu{C}), 38.1 (ddd, 1JPC = 17.8,
3JPC = 7,
2JPC = 3, tBu{C}), 35.8 (d,
JPC = 11, CH2), 31.3 (s, CH2), 30.9 (dd,
1JPC = 15,
3JPC = 3, PCH2),
30.7 (s, CH2), 30.5 (s, CH2), 30.3 (s, CH2), 30.0 (s, CH2), 29.2 (s,
CH2), 28.6 (s, CH2), 28.2 (s, CH2), 28.0 (d, JPC = 7, CH2), 27.5 (d,
2JPC = 5, tBu{CH3}), 25.0 (d app t,
1JPC = 14, J = 3, PCH2), 24.4 (d,
2JPC = 4, tBu{CH3}), 24.2 (d, JPC = 4, CH2), 23.7 (s, CH2).
31P{1H} NMR (162 MHz, CD2Cl2): δ 191.1 (dd,
2JPP = 373,
1JRhP = 110, 1P), 182.9 (dd,
2JPP = 373,
1JRhP = 121, 1P).
HR ESI-MS (positive ion, 4 kV): 736.2909, [M]+ (calcd
736.2914) m/z.
Anal. Calcd for C71H69BF24NO2P2Rh (1599.96 g mol
−1): C,
53.30; H, 4.35; N, 0.88; Found: C, 53.12; H, 4.48; N, 0.86.
General procedure for in situ synthesis of dihydrogen
complexes 7
A solution of 6 in DFB (0.5 mL) was freeze–pump–thaw
degassed and placed under dihydrogen (1 atm) within a J
Young’s valve NMR tube and heated at 85 °C to afford the
corresponding dihydrogen complex, which was characterised
in situ under dihydrogen, and biphenyl.
[Rh(PNP-14)(H2)][BAr
F
4] (7a). Following the general pro-
cedure using 6a (16.0 mg, 10.0 µmol) and heating for 2 days at
85 °C gave quantitative conversion to 7a by 1H and 31P NMR
spectroscopy.
1H NMR (500 MHz, DFB, H2): δ 8.09–8.15 (m, 8H, Ar
F), 7.54
(t, 3JHH = 7.8, 1H, py), 7.49 (br, 4H, Ar
F), 7.22 (obscured 2H,
py), 3.46 (dvt, 2JHH = 17.7, JPH = 4, 2H, pyCH̲2), 3.23 (dvt,
2JHH =
17.7, JPH = 4, 2H, pyCH2̲), 1.51–1.71 (m, 10H, CH2), 1.14–1.41
(m, 18H, CH2), 0.94 (vt, JPH = 8, 18H, tBu), −10.43 (vbr, fwhm
∼800 Hz, 2H, RhH).
13C{1H} NMR (126 MHz, DFB, H2): δ 164.1 (vt, JPC = 5, py),
162.3 (q, 1JCB = 50, Ar
F), 140.1 (s, py), 135.4 (s, ArF), 129.6 (qq,
2JFC = 32,
3JCB = 3, Ar
F), 125.2 (q, 1JFC = 272, Ar
F), 121.1 (vt, JPC =
5, py), 117.6 (sept, 3JFC = 4, Ar
F), 37.9 (vt, JPC = 9, pyC̲H2), 32.0
(vt, JPC = 12, tBu{C}), 28.7 (vt, JPC = 4, CH2), 28.5 (s, CH2), 28.4 (s,
CH2), 28.0 (s, CH2), 27.0 (s, CH2), 26.4 (vt, JPC = 3, tBu{CH3}),
24.7 (vt, JPC = 3, CH2), 20.8 (vtd, JPC = 12,
2JRhC = 2, PCH2).
31P{1H} NMR (162 MHz, DFB, H2): δ 65.9 (d,
1JRhP = 120).
1H NMR (600 MHz, DFB, selected data under argon):
δ −10.76 (vbr, fwhm = 60 Hz, T1 = 45 ± 11 ms, 2H, RhH).
[Rh(PONOP-14)(H2)][BAr
F
4] (7b). Following the general pro-
cedure using 6b (12.0 mg, 7.50 µmol) and heating for 5 days at
85 °C gave quantitative conversion to 7b by 1H and 31P NMR
spectroscopy.
1H NMR (500 MHz, DFB, H2): δ 8.09–8.15 (m, 8H, Ar
F), 7.63
(t, 3JHH = 8.2, 1H, py), 7.49 (br, 4H, Ar
F), 6.63 (obscured 2H,
py), 2.03–2.18 (m, 4H, CH2), 1.53–1.78 (m, 6H, CH2), 1.15–1.41
(m, 18H, CH2), 1.11 (vt, JPH = 8, 18H, tBu), −8.65 (vbr, fwhm =
100 Hz, 2H, RhH).
13C{1H} NMR (126 MHz, DFB, H2): δ 163.5 (br, py), 162.3 (q,
1JCB = 50, Ar
F), 145.9 (s, py), 135.4 (s, ArF), 129.6 (qq, 2JFC = 32,
3JCB = 3, Ar
F), 125.2 (q, 1JFC = 272, Ar
F), 117.6 (sept, 3JFC = 4,
ArF), 103.3 (vt, JPC = 3, py), 37.6 (vt, JPC = 12, tBu{C}), 29.0 (br,
CH2), 28.5 (s, CH2), 28.1 (s, CH2), 28.0 (s, CH2), 27.5 (vt, JPC =
9, PCH2), 27.3 (s, CH2), 24.7 (vt, JPC = 4, tBu{CH3}), 23.9 (vt,
JPC = 3, CH2).
31P{1H} NMR (162 MHz, DFB, H2): δ 211.5 (d,
1JRhP = 127).
1H NMR (600 MHz, DFB, selected data under argon): δ −8.51
(vbr d, fwhm = 60 Hz, 1JRhH = 21, T1 = 48 ± 6 ms, 2H, RhH).
General procedure for in situ synthesis of ethylene complexes 8
A solution of 7 in DFB (0.5 mL) was freeze–pump–thaw
degassed and placed under ethylene (1 atm) within a J Young’s
valve NMR tube to afford the corresponding ethylene complex,
which was characterised in situ under ethylene. All spectra con-
tained ethane (δ1H 0.70).
[Rh(PNP-14)(C2H4)][BAr
F
4] (8a). Following the general pro-
cedure using 7a (10 µmol, generated in situ as described
above) gave quantitative conversion to 8a by 1H and 31P NMR
spectroscopy within 5 minutes at room temperature.
1H NMR (500 MHz, DFB, C2H4): δ 8.09–8.15 (m, 8H, Ar
F),
7.51 (t, 3JHH = 8.0, 1H, py), 7.49 (br, 4H, Ar
F), 7.15 (obscured,
2H, py), 3.70 (br, 2H, C2H4), 3.52 (br, 2H, C2H4), 3.31 (dvt,
2JHH = 17.3, JPH = 4, 2H, pyCH̲2), 3.22 (dvt,
2JHH = 17.4, JPH = 4,
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2H, pyCH̲2), 1.72–1.93 (m, 4H, CH2), 1.55–1.67 (m, 2H, CH2),
1.39–1.50 (m, 2H, CH2), 1.07–1.37 (m, 20H, CH2), 0.83 (vt,
JPH = 7, 18H, tBu).
13C{1H} NMR (126 MHz, DFB, C2H4): δ 162.9 (vt, JPH = 5,
py), 162.3 (q, 1JCB = 50, Ar
F), 140.1 (s, py), 135.1 (s, ArF), 129.6 (qq,
2JFC = 32,
3JCB = 3, Ar
F), 125.2 (q, 1JFC = 272, Ar
F), 120.7 (vt, JPC = 5,
py), 117.6 (sept, 3JFC = 4, Ar
F), 55.0 (d, 1JRhC = 12, C2H4), 37.5 (vt,
JPC = 8, pyC̲H2), 32.8 (vt, JPC = 10, tBu{C}), 29.5 (vt, JPC = 4, CH2),
29.3 (s, CH2), 28.7 (s, CH2), 28.2 (s, CH2), 27.9 (s, CH2), 26.6 (vt,
JPC = 3, tBu{CH3}), 24.1 (s, CH2), 21.9 (vt, JPC = 10, PCH2).
31P{1H} NMR (162 MHz, DFB, C2H4): δ 53.0 (d,
1JRhP = 125).
[Rh(PONOP-14)(C2H4)][BAr
F
4] (8b). Following the general
procedure using 7b (7.5 µmol, generated in situ as described
above) gave quantitative conversion to 8a by 1H and 31P NMR
spectroscopy within 5 minutes at room temperature.
1H NMR (500 MHz, DFB, C2H4): δ 8.09–8.15 (m, 8H, Ar
F),
7.61 (t, 3JHH = 8.1, 1H, py), 7.49 (br, 4H, Ar
F), 6.59 (obscured
2H, py), 3.95 (br, 2H, C2H4), 3.70 (br, 2H, C2H4), 2.19–2.29 (m,
2H, CH2), 2.05–2.16 (m, 2H, CH2), 1.74–1.86 (m, 2H, CH2),
1.46–1.60 (m, 4H, CH2), 1.02–1.45 (m, 18H, CH2), 0.96 (vt,
JPH = 8, 18H, tBu).
13C{1H} NMR (126 MHz, DFB, C2H4): δ 162.8 (vt, JPC = 3,
py), 162.3 (q, 1JCB = 50, Ar
F), 145.3 (s, py), 135.1 (s, ArF), 129.6
(qq, 2JFC = 32,
3JCB = 3, Ar
F), 125.2 (q, 1JFC = 272, Ar
F), 117.6
(sept, 3JFC = 4, Ar
F), 103.2 (vt, JPC = 3, py), 59.5 (d,
1JRhC = 11,
C2H4), 39.1 (vt, JPC = 10, tBu{C}), 30.0 (vt, JPC = 2, CH2), 28.7 (s,
CH2), 28.6 (s, CH2), 28.5 (s, CH2), 28.4 (s, CH2), 27.3 (vtd, JPC =
8, 2JRhC = 2, PCH2), 24.9 (vt, JPC = 3, tBu{CH3}), 23.7 (s, CH2).
31P{1H} NMR (162 MHz, DFB, C2H4): δ 199.1 (d,
1JRhP = 129).
General procedure for the preparation of carbonyl complexes 9
A solution of 8 in DFB (0.5 mL) was freeze–pump–thaw
degassed and placed under carbon monoxide (1 atm) within a
J Young’s valve NMR tube, resulting in an immediate colour
change. The volatiles were removed in vacuo, and the resulting
yellow solid washed and dried in vacuo.
Preparation of [Rh(PNP-14)(CO)][BArF4] (9a). Following the
general procedure using 8a (10 µmol, generated in situ as
described above), washing with hexane afforded the pure
product as a yellow solid. Yield: 14.1 mg (96%).
1H NMR (500 MHz, CD2Cl2): δ 7.79 (t,
3JHH = 7.8, 1H, py),
7.70–7.76 (m, 8H, ArF), 7.56 (br, 4H, ArF), 7.42 (d, 3JHH = 7.9,
2H, py), 3.70 (dvt, 2JHH = 17.5, JPH = 4, 2H, pyCH̲2), 3.56 (dvt,
2JHH = 17.5, JPH = 4, 2H, pyCH̲2), 2.02–2.09 (m, 4H, CH2),
1.78–1.98 (m, 4H, CH2), 1.63–1.75 (m, 2H, CH2), 1.49–1.63 (m,
2H, CH2), 1.21–1.49 (m, 16H, CH2), 1.13 (vt, JPH = 8, 18H, tBu).
13C{1H} NMR (126 MHz, CD2Cl2): δ 194.7 (dt,
1JRhC = 70,
2JPC = 13, CO), 163.8 (vtd, JPC = 5,
2JRhC = 1, py), 162.3 (q,
1JCB =
50, ArF), 141.6 (s, py), 135.4 (s, ArF), 129.4 (qq, 2JFC = 32,
3JCB =
3, ArF), 125.2 (q, 1JFC = 272, Ar
F), 122.1 (vt, JPC = 5, py), 118.0
(sept, 3JFC = 4, Ar
F), 38.7 (vt, JPC = 9, pyC̲H2), 33.9 (vt, JPC = 12,
tBu{C}), 30.3 (vt, JPC = 4, CH2), 29.3 (s, CH2), 28.94 (s, CH2),
28.88 (s, CH2) 28.4 (s, CH2), 27.8 (vt, JPC = 3, tBu{CH3}), 26.2 (s,
CH2), 23.2 (vtd, JPC = 12,
2JRhC = 3, PCH2).
31P{1H} NMR (162 MHz, CD2Cl2): δ 67.5 (d,
1JRhP = 122).
IR (CH2Cl2): ν(CO) 1997 cm
−1.
HR ESI-MS (positive ion, 4 kV): 608.2653, [M]+ (calcd
608.2652) m/z.
Anal. Calcd for C62H65BF24NOP2Rh (1471.83 g mol
−1): C,
50.60; H, 4.45; N, 0.95 Found: C, 50.53; H, 4.47; N, 1.08.
[Rh(PONOP-14)(CO)][BArF4] (9b). Following the general pro-
cedure using 8b (7.5 µmol, generated in situ as described
above), washing with hexane afforded the pure product as a
yellow solid. Crystals suitable for X-ray crystallography were
grown by the slow diffusion of SiMe4 into CH2Cl2 at −30 °C.
Yield: 8.0 mg (72%).
1H NMR (500 MHz, CD2Cl2): δ 7.91 (t,
3JHH = 8.2, 1H, py),
7.70–7.76 (m, 8H, ArF), 7.56 (br, 4H, ArF), 6.86 (d, 3JHH = 8.2,
2H, py), 2.40–2.60 (m, 4H, CH2), 1.76–1.98 (m, 6H, CH2),
1.52–1.65 (m, 3H, CH2), 1.11–1.48 (m, 15H, CH2), 1.29 (vt,
JPH = 8, 18H, tBu).
13C{1H} NMR (126 MHz, CD2Cl2): δ 193.2 (dt,
1JRhC = 71,
2JPC = 13, CO), 163.1 (vt, JPC = 3, py), 162.3 (q,
1JCB = 50, Ar
F),
147.7 (s, py), 135.4 (s, ArF), 129.5 (qq, 2JFC = 32,
3JCB = 3, Ar
F),
125.2 (q, 1JFC = 272, Ar
F), 118.0 (sept, 3JFC = 4, Ar
F), 104.5 (vt,
JPC = 3, py), 39.9 (vtd, JPC = 11,
2JRhC = 2, tBu{C}), 30.9 (vt, JPC =
2, CH2), 29.5 (vtd, JPC = 9,
2JRhC = 3, PCH2), 29.3 (s, CH2), 29.1
(s, 2 × CH2), 28.8 (s, CH2), 26.1 (vt, JPC = 4, tBu{CH3}), 25.1 (vt,
JPC = 2, CH2).
31P{1H} NMR (162 MHz, CD2Cl2): δ 210.8 (d,
1JRhP = 128).
IR (CH2Cl2): ν(CO) 2020 cm
−1.
HR ESI-MS (positive ion, 4 kV): 612.2228, [M]+ (calcd
612.2237) m/z.
Anal. Calcd for C60H61BF24NO3P2Rh (1475.78 g mol
−1): C,
48.83; H, 4.17; N, 0.95 Found: C, 48.91; H, 4.26; N, 1.02.
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